Human Papillomavirus 16 Lineage D is Associated with High Risk of Cervical Cancer in the Brazilian Northeast Region

被引:0
作者
Martins, Luis Felipe Leite [1 ]
Moreira, Miguel Angelo Martins [2 ]
Pinto, Rodrigo Alves [3 ]
Reis, Neilane Bertoni dos [4 ]
Felix, Shayany Pinto [2 ]
Vidal, Joao Paulo Castello Branco [5 ]
Torres, Leuridan Cavalcante [3 ]
Souza, Ariani Impieri [3 ,7 ]
de Almeida, Liz Maria [6 ]
机构
[1] Inst Nacl Canc, Canc Surveillance & Data Anal Div, Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Canc, Tumor Genet & Virol Program, Rio De Janeiro, RJ, Brazil
[3] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil
[4] Inst Nacl Canc, Div Populat Res, Rio De Janeiro, RJ, Brazil
[5] Univ Fed Maranhao, Sao Luis, MA, Brazil
[6] Inst Nacl Canc, Coordinat Prevent & Surveillance, Rio De Janeiro, RJ, Brazil
[7] Rua Coelhos, 300, BR-50070902 Recife, PE, Brazil
来源
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2023年 / 45卷 / 08期
关键词
HPV16; lineage A; lineage D; CIN2/CIN3; cervical cancer; VARIANTS; TYPE-16; LESIONS; HPV16; WOMEN; CARCINOMA; DIVERSITY; E6;
D O I
10.1055/s-0043-1772180
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective Similar to Human Papillomavirus (HPV) genotypes, different lineages of a genotype also have different carcinogenic capabilities. Studies have shown that specific genotype lineages of oncogenic HPV are associated with variable risks for the development of cervical intraepithelial neoplasia (CIN2/CIN3) and cervical cancer. The present study aimed to analyze the genetic diversity of the HPV16 genotype in women with CIN2/CIN3 and cervical cancer, from the northeast region of Brazil.Methods A cross-sectional multicenter study was conducted in the northeast region of Brazil, from 2014 to 2016. This study included 196 cases of HPV16 variants (59 and 137 cases of CIN2/CIN3 and cervical cancer, respectively). The difference of proportion test was used to compare patients with CIN2/CIN3 and cervical cancer, based on the prevalent HPV16 lineage ( p < 0.05).Results According to the histopathological diagnosis, the percentage of lineage frequencies revealed a marginal difference in the prevalence of lineage A in CIN2/CIN3, compared with that in cervical cancer ( p = 0.053). For lineage D, the proportion was higher in cancer cases (32.8%), than in CIN2/CIN3 cases (16.9%), with p = 0.023.Conclusion HPV16 lineage A was the most frequent lineage in both CIN2/CIN3 and cervical cancer samples, while lineage D was predominant in cervical cancer, suggesting a possible association between HPV16 lineage D and cervical cancer.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 50 条
  • [41] Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer
    Combes, Jean-Damien
    Pawlita, Michael
    Waterboer, Tim
    Hammouda, Doudja
    Rajkumar, Thangarajan
    Vanhems, Philippe
    Snijders, Peter
    Herrero, Rolando
    Franceschi, Silvia
    Clifford, Gary
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (10) : 2453 - 2461
  • [42] Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue
    Zou, Ruanmin
    Xie, Wangkai
    Wang, Huijing
    Wang, Jian
    Xiao, Lanlan
    Ji, Shuhui
    Chen, Xiangmin
    Zhang, Lifang
    Xue, Xiangyang
    Chen, Jun
    CLINICAL LABORATORY, 2016, 62 (06) : 1075 - 1085
  • [43] The immune function differences and high-risk human papillomavirus infection in the progress of cervical cancer
    Li, Changdong
    Ma, Cui
    Zhang, Weiyuan
    Wang, Jiandong
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (05) : 557 - 561
  • [44] The E6 gene polymorphism of Human papillomavirus 16 in relation to the risk of cervical cancer in Tunisian women
    Rhouma, Rahima Bel Haj
    Ardhaoui, Monia
    Othman, Houcemeddine
    Ben Jemia, Zeineb
    El Abidine, Amira Zine
    Fehri, Emna
    Ouerheni, Kaouther
    Laassili, Thalja
    Tounsi, Haifa
    Guizani, Ikram
    Boubaker, Med Samir
    Ennaifer, Emna
    INFECTION GENETICS AND EVOLUTION, 2023, 116
  • [45] Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer
    Berkhof, Johannes
    Bogaards, Johannes A.
    FUTURE ONCOLOGY, 2010, 6 (12) : 1817 - 1821
  • [46] Human papillomavirus 16E6 oncogene mutation in cervical cancer
    Sun, Feng
    Ha, Xiao-qin
    Lv, Tong-de
    Xing, Chuan-ping
    Liu, Bin
    Cao, Xiao-zhe
    CHINESE JOURNAL OF CANCER RESEARCH, 2009, 21 (02) : 97 - 101
  • [47] Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer
    Berza, Natalija
    Zodzika, Jana
    Kivite-Urtane, Anda
    Baltzer, Nicholas
    Curkste, Alise
    Pole, Ilva
    Nygard, Mari
    Parna, Kersti
    Stankunas, Mindaugas
    Tisler, Anna
    Uuskula, Anneli
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34 (04) : 826 - 832
  • [48] Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
    Kailash, U.
    Soundararajan, C. C.
    Lakshmy, R.
    Arora, R.
    Vivekanandhan, S.
    Das, B. C.
    BRITISH JOURNAL OF CANCER, 2006, 95 (09) : 1250 - 1257
  • [49] Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
    U Kailash
    C C Soundararajan
    R Lakshmy
    R Arora
    S Vivekanandhan
    B C Das
    British Journal of Cancer, 2006, 95 : 1250 - 1257
  • [50] High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020
    Boni, Simon P.
    Tenet, Vanessa
    Horo, Apollinaire
    Heideman, Danielle A. M.
    Bleeker, Maaike C. G.
    Tanon, Aristophane
    Mian, Boston
    Mohenou, Isidore D.
    Ekouevi, Didier K.
    Gheit, Tarik
    Didi-Kouko Coulibaly, Judith
    Tchounga, Boris K.
    Adoubi, Innocent
    Clifford, Gary M.
    Jaquet, Antoine
    IeDEA West Africa Collaboration
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (06) : 962 - 968